Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002

Wake Forest University Health Sciences v Smith & Nephew Pty Ltd (No 2) [2011] FCA 1002

Smith & Nephew did not infringe any claims of the patent, as KCI failed to prove S&N’s product possessed the essential 'screen means sufficiently rigid to prevent wound overgrowth' integer required by all claims in suit. This integer was also held to lack scientific meaning, rendering all claims in suit invalid for lack of clarity and sufficiency required by ss 40(2) and (3) of the Patents Act 1990 (Cth). Claim 49 was additionally invalid as a mere collocation. Novelty and inventive step grounds were not established independent of the key deficiency.

Parties
First Applicant / First Cross Respondent: Wake Forest University Health Sciences; Second Applicant / Second Cross Respondent: KCI Medical Australia Pty Ltd (ACN 056 073 468); Respondent / Cross Claimant: Smith & Nephew Pty Ltd (ACN 000 087 507)
Jurisdiction
Australia
Judgment Date
30 August 2011
Procedural Posture
Patent Infringement and Revocation Proceeding / Final Judgment After Full Trial
Outcome
Application dismissed; Cross-claim allowed
Legal Topics
Patent Infringement, Validity of Patents, Construction of Patent Claims, Inventive Step, Novelty, Method of Medical Treatment, Combination Patents

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 5 Authorities cited 74 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Wake Forest University Health Sciences

First Applicant / First Cross Respondent

KCI Medical Australia Pty Ltd (ACN 056 073 468)

Second Applicant / Second Cross Respondent

Smith & Nephew Pty Ltd (ACN 000 087 507)

Respondent / Cross Claimant

Procedural Posture

Patent Infringement and Revocation Proceeding / Final Judgment After Full Trial

  1. 1 Whether Smith & Nephew infringed the claims of the KCI/Wake Forest patent
  2. 2 Whether the claims of the patent are valid, including for sufficiency, clarity, inventive step, novelty and manner of manufacture
  3. 3 Construction of key patent claim terms (notably 'screen means sufficiently rigid to prevent wound overgrowth')

Ratio Decidendi

Smith & Nephew did not infringe any claims of the patent, as KCI failed to prove S&N’s product possessed the essential 'screen means sufficiently rigid to prevent wound overgrowth' integer required by all claims in suit. This integer was also held to lack scientific meaning, rendering all claims in suit invalid for lack of clarity and sufficiency required by ss 40(2) and (3) of the Patents Act 1990 (Cth). Claim 49 was additionally invalid as a mere collocation. Novelty and inventive step grounds were not established independent of the key deficiency.

Court Disposition

Application dismissed; Cross-claim allowed

Orders

  • Application by KCI and Wake Forest dismissed
  • Cross-claim by Smith & Nephew allowed